4//SEC Filing
Brown Victoria L. 4
Accession 0001127602-20-026748
CIK 0001492422other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:45 PM ET
Size
8.3 KB
Accession
0001127602-20-026748
Insider Transaction Report
Form 4
Brown Victoria L.
Program Team Lead
Transactions
- Exercise/Conversion
Common Stock
2020-10-07$18.98/sh+12,000$227,760→ 15,607 total - Sale
Common Stock
2020-10-07$35.00/sh−12,000$420,000→ 3,607 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-10-07−12,000→ 39,268 totalExercise: $18.98Exp: 2029-03-06→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]This includes 482 shares acquired under the ESPP Purchase on April 30, 2020.
- [F2]This option was granted on March 7, 2019 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001810475
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:45 PM ET
- Size
- 8.3 KB